Recent Finacing
Recent Raise
Exciva is a Heidelberg-based biopharmaceutical company developing Deraphan, a combination therapy aimed at treating agitation associated with Alzheimer’s disease and other neuropsychiatric disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Exciva.
